Rapid desensitization of adrenaline‐ and neuropeptide Y‐stimulated Ca2+ mobilization in HEL‐cells
Open Access
- 1 June 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 112 (2) , 499-504
- https://doi.org/10.1111/j.1476-5381.1994.tb13101.x
Abstract
Desensitization of Gs‐coupled receptors, the β2‐adrenoceptor for example, involves rapid and slower components but little is known regarding the existence of rapid desensitization of Gi‐coupled receptors and its possible mechanisms. In HEL‐cells stimulation of α2A‐adrenoceptors by adrenaline or Y1‐like neuropeptide Y receptors by neuropeptide Y, transiently mobilizes Ca2+ from intracellular stores via a Gi‐protein. We have used this model to study the existence and possible mechanisms of rapid desensitization of a Gi‐mediated cellular response. Following stimulation by adrenaline or neuropeptide Y Ca2+ levels returned towards baseline a few minutes after agonist addition and were refractory to a second agonist exposure demonstrating rapid desensitization. Cross‐desensitization experiments with neuropeptide Y, adrenaline and moxonidine demonstrated the presence of homologous (both receptors) and heterologous desensitization (neuropeptide Y receptors only), and that the α2A‐adrenoceptor desensitization was not specific for phenylethylamine (adrenaline) or imidazoline agonists (moxonidine). The protein kinase C activator, phorbol ester, rapidly desensitized the hormonal Ca2+ responses and inhibitors of protein kinase C enhanced the hormonal responses inconsistently. The tyrosine kinase inhibitor, herbimycin, enhanced Ca2+ mobilization by adrenaline and neuropeptide Y, whereas the protein phosphatase inhibitor, okdadaic acid, did not affect Ca2+ mobilization or its desensitization. In the absence of extracellular Ca2+ the endoplasmic reticulum Ca2+‐ATPase inhibitor, thapsigargin, reduced hormone‐stimulated Ca2+ elevations, demonstrating that mobilization occurs from a thapsigargin‐sensitive pool in the endoplasmic reticulum. The inositol phosphate‐independent Ca2+ release modulator, ryanodine, significantly enhanced adrenaline‐ and neuropeptide Y‐stimulated Ca2+ elevations. Blockade of the endoplasmic reticulum Ca2+‐ATPase by thapsigargin in the presence of extracellular Ca2+ enhanced hormone‐stimulated Ca2+ increases, demonstrating the importance of this enzyme for the termination of the Ca2+ signal. It is concluded that adrenaline and neuropeptide Y‐stimulated Ca2+ mobilization in HEL‐cells occurs from a thapsigargin‐ and ryanodine‐sensitive store in the endoplasmic reticulum and desensitizes rapidly; this appears to involve multiple mechanisms including protein kinases, possibly acting on receptors, and Ca2+ release and sequestration mechanisms.Keywords
This publication has 38 references indexed in Scilit:
- Norepinephrine and Neuropeptide Y Increase Intracellular Ca2+ in Cultured Porcine Aortic Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1993
- Ryanodine receptors: how many, where and why?Trends in Pharmacological Sciences, 1993
- The activation of inactive membrane-associated protein kinase C is associated with DMSO-induced erythroleukemia cell differentiationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Okadaic acid inhibits angiotensin II stimulation of Ins(1,4,5)P3 and calcium signalling in rat hepatocytesFEBS Letters, 1992
- α2A- and α2C-Adrenoceptor subtypes are differentially down-regulated by norepinephrineEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Nitrendipine-induced inhibition of calcium influx in a human T-cell clone: Role of cell depolarizationCell Calcium, 1991
- Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclaseFEBS Letters, 1990
- Neuropeptide Y‐induced intracellular Ca2+ increases in vascular smooth muscle cellsFEBS Letters, 1989
- Cloning, Sequencing, and Expression of the Gene Coding for the Human Platelet α 2 -Adrenergic ReceptorScience, 1987
- Lack of cross-desensitization between structurally dissimilar α-adrenoceptor agonistsJournal of Pharmacy and Pharmacology, 1977